KRAS and lung carcinoma: In addition, there are co-mutated genes such as ATM serine/threonine kinase gene (ATM), MNNG HOS Transforming gene (MET), and erb-b2 receptor tyrosine kinase 2 gene (ERBB2), which account for more than 10% of patients with KRAS mutated lung cancer [46].